Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 34Leukemia 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Hematologic Neoplasms 4Recurrence 3Neoplasms 2Thrombocytopenia 1Sarcoma, Myeloid 1Sarcoma, Kaposi 1Neoplasm, Residual 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Leukemia, Myeloid 1Immunoproliferative Disorders 1HIV Infections 1Disease 1Congenital Abnormalities 1Acquired Immunodeficiency Syndrome 1

Interventions

fluciclovine F-18 2Positron-Emission Tomography 2Injections 2Dexamethasone 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2tislelizumab 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1pembrolizumab 1lortalamine 1gossypol acetic acid 1daratumumab 1aflibercept 1Prednisone 1Oncolytic Virotherapy 1Octreotide 1Mitomycin 1Mammography 1Lenalidomide 1Ipilimumab 1Drug Delivery Systems 1Docetaxel 1Diagnosis, Computer-Assisted 1Daunorubicin 1Cytarabine 1Control Groups 1CPX-351 1Bevacizumab 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Disease × Daunorubicin × Clear all
NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Jazz Pharmaceuticals

Phase 2 Completed
126 enrolled 12 charts
Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡